Xylyx Bio

Xylyx Bio creates effective science-based solutions for the benefit of human life and health. Xylyx Bio is a biomaterials pioneer, providing customers with products for research, clinical, and commercial applications. The company's solutions provide scientists engaged in pharmaceutical development, cell biology research, and regenerative medicine with the complete spectrum of components from the natural cell microenvironment required for precise and actionable results.

Xylyx Bio headquartered in New York, United States, North America, operates in the Biotechnology, Life Science, Health Care sector. The company focuses on Biotechnology and has secured $224.9M in funding across 48 round(s). With a team of 11-50 employees, Xylyx Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Xylyx Bio, raised $2.3M. Discover more about their projects, partnerships, and impact on our platform.